910
MODELING OPTIMAL STOPPING AGES FOR COLORECTAL CANCER SCREENING BASED ON SEX, COMORBIDITY, AND SCREENING HISTORY
Date
May 20, 2024
Tracks
Related Products
CHARACTERISTICS OF A COST-EFFECTIVE BLOOD TEST FOR COLORECTAL CANCER SCREENING
Blood-based biomarker tests have been developed as a non-invasive colorectal cancer (CRC) screening method to triage patients to colonoscopy…
COST-EFFECTIVENESS OF RISK-STRATIFIED SCREENING FOR COLORECTAL CANCER BASED ON PRIOR FECAL HEMOGLOBIN LEVELS
There is growing evidence that the balance between harms and benefits of colorectal cancer (CRC) screening can be improved using risk stratification…
RISK STRATIFICATION IN FIT-BASED COLORECTAL CANCER SCREENING: INTERVAL CANCER RISK AFTER THE UPPER AGE LIMIT OF SCREENING HAS BEEN REACHED
Colorectal cancer (CRC) screening programmes have been shown effective in reducing CRC incidence and mortality. Risk stratification offers opportunities for further optimisation of screening programmes by better balancing the harms and benefits of screening…
SHOULD WE SCREEN MALES AND FEMALES DIFFERENTLY FOR COLORECTAL CANCER? A COST-EFFECTIVENESS ANALYSIS
Most colorectal cancer (CRC) screening programs use a uniform screening strategy. However, it may be more efficient to screen males and females differently due to (ambivalent) biological and demographic differences between the sexes…